Financhill
Back

Alnylam Pharmaceuticals 10K Form

Sell
48

ALNY
Alnylam Pharmaceuticals

Last Price:
249.69
Seasonality Move:
8.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ALNY News And Ratings

See the #1 stock for the next 7 days that we like better than ALNY

ALNY Financial Statistics

Sales & Book Value

Annual Sales: $1.83B
Cash Flow: $-94.49M
Price / Cash Flow: 248.1
Annual Sales: $-1.73
Price / Book: 0

Profitability

EPS (TTM): -2.68000
Net Income (TTM): $-332.08M
Gross Margin: $1.52B
Return on Equity: 0%
Return on Assets: -9.08%

Alnylam Pharmaceuticals Earnings Forecast

Key Alnylam Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ALNY is 83.02%.
  • The Selling, General & Administrative Expenses for ALNY have been equal to 43.52% of Gross Profit Margin.
  • The Research & Development expenses have been 54.94% of Revenue.
  • The Interest Expense is -27.54% of Operating Income.
  • The Net Earning history of ALNY is -24.08% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Alnylam Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALNY
CUSIP: 02043Q
Website: alnylam.com

Debt

Debt-to-Equity Ratio: -4.66
Current Ratio: 3.17
Quick Ratio: 2.86

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALNY Technical Analysis vs Fundamental Analysis

Sell
48
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy or a Sell?